| Aug 28 |
Exact Sciences to Participate in September Investor Conferences
|
| Aug 23 |
Should You Believe in the Growth Potential of Exact Sciences Corporation (EXAS)?
|
| Aug 22 |
Does Exact Sciences (EXAS) Have the Potential to Rally 34.13% as Wall Street Analysts Expect?
|
| Aug 22 |
Exact Sciences (EXAS) Rides on Cologuard Sales, New Launches
|
| Aug 22 |
Exact Sciences (EXAS) Enrolls First Patient in Pivotal MCED Study
|
| Aug 21 |
Here’s Why Baron Opportunity Fund Sold its Stake in Exact Sciences Corp (EXAS)
|
| Aug 21 |
Exact Sciences kicks off multi-cancer detection study
|
| Aug 20 |
Exact Sciences Announces First Patient Enrolled in its Multi-Cancer Early Detection (MCED) Falcon Registry Real-World Evidence Study
|
| Aug 18 |
Exact Sciences: Cost Optimization And Product Strength
|
| Aug 16 |
Exact Sciences data finds Cologuard detected almost 600k cancer cases
|
